DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Navari RM, Rapoport BL, Powers D, Arora S, Clark-Snow R.
Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy.

Cancer Med 2018;
7: 2943-2950

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: